Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Real-world efficacy, safety and heterogenicity of efficacy of elexacaftor-tezacaftor-ivacaftor in younger children (6-11 years old) with cystic fibrosis.
Journal: Respiratory medicine
Published: April 06, 2026
Real-world Efficacy, Safety and Heterogenicity of Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in Younger Children (6-11 Years Old) with Cystic Fibrosis.
Journal: Respiratory medicine
Published: April 06, 2026
Evaluation of Methicillin-Resistant Staphylococcus aureus Eradication in People With Cystic Fibrosis.
Journal: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
Published: October 20, 2025
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis.
Journal: Pediatric pulmonology
Published: September 29, 2025
Real -world impact of previous exposure to CFTR modulators on clinical parameters and chronic sinus disease in people with cystic fibrosis on elexacaftor-tezacaftor-ivacaftor.
Journal: Respiratory medicine
Published: March 24, 2025
Intermittent Asthma and Risk of Severe Exacerbation in Children.
Journal: Chest
Published: March 17, 2025
A New Simple to Use Chest CT Scoring System: Validation Study.
Journal: Pediatric pulmonology
Published: February 07, 2025
Real-life impact of genotype and severity of lung disease on efficacy of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis.
Journal: Pulmonary pharmacology & therapeutics
Published: November 12, 2024
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis.
Journal: Frontiers in immunology
Published: August 26, 2024
Innate immune responses are increased in children with acute asthma exacerbation.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: February 20, 2024
Elexacaftor-Tezacaftor-Ivacaftor Therapy for Chronic Sinus Disease in Cystic Fibrosis.
Journal: JAMA otolaryngology-- head & neck surgery
Published: September 07, 2023
Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis.
Journal: Pediatric pulmonology
Published: November 15, 2022
Last Updated: 09/26/2026